Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Rejection is the major barrier to successful transplantation and usually results from the integration of multiple mechanisms. Activation of elements of the innate immune system, triggered as a consequence of tissue injury sustained during cell isolation or organ retrieval as well as ischemia-reperfusion, will initiate and amplify the adaptive response. For cell mediated rejection, T cells require multiple signals for activation, the minimum being two signals; antigen recognition and costimulation. The majority of B cells require help from T cells to initiate alloantibody production. Antibodies reactive to donor HLA molecules, minor histocompatibility antigens, endothelial cells, red blood cells, or autoantigens can trigger or contribute to rejection early as well as late after transplantation.

Original publication

DOI

10.1007/978-1-62703-493-7_3

Type

Journal article

Journal

Methods Mol Biol

Publication Date

2013

Volume

1034

Pages

71 - 83

Keywords

Antibodies, B-Lymphocytes, Endothelial Cells, Erythrocytes, Graft Rejection, Humans, Immunity, Innate, Minor Histocompatibility Antigens, Molecular Biology, T-Lymphocytes, Transplantation, Homologous